Dendritic cells generated from CD34+ progenitor cells with flt3 ligand, c-kit ligand, GM-CSF, IL-4, and TNF-α are functional antigen-presenting cells resembling mature monocyte-derived dendritic cells

被引:55
作者
Ferlazzo, G
Klein, J
Paliard, X
Wei, WZ
Galy, A
机构
[1] Wayne State Univ, Karmanos Canc Inst, Detroit, MI 48201 USA
[2] Chiron Corp, Emeryville, CA 94608 USA
来源
JOURNAL OF IMMUNOTHERAPY | 2000年 / 23卷 / 01期
关键词
dendritic cells; CD34; monocyte; T lymphocyte activation; breast cancer;
D O I
10.1097/00002371-200001000-00007
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Dendritic cells (DCs) are powerful antigen-presenting cells. Because DCs are rare cells, methods to produce them in vitro are valuable ways to study their biologic properties and to generate cells for immunotherapy. This study defines the antigen-presenting properties of DCs generated in vitro from CD34(+) cells of patients with breast cancer. The combination of cytokines flt3 ligand + c-kit ligand + granulocyte-macrophage colony-stimulating factor (GM-CSF) + interleukin-4 (IL-4) + tumor necrosis factor-alpha (TNF-alpha) was used to maximize the output of mature DCs in the culture of CD34(+) cells while minimizing the production of monocytes. Cells grew and differentiated into DCs as measured by a time-dependent upregulation of cell surface antigens major histocompatibility complex class II, CD1a, CD80, CD86, CD40, and CD4, so that 40% +/- 9% (n = 6) of cells in culture at day 15 were CD1a(+)CD14(-). Markers were acquired in the same sequence as on monocytes induced to differentiate with GM-CSF + IL-4, Differentiation was marked by a rime-dependent increase in allostimulatory function, which, at its peak, was more potent than in cultures of DCs generated from monocytes with GM-CSF + IL-4, but was comparable on a cell-to-cell basis to that of mature monocytes cultured in flt3-ligand + c-kit-ligand + GM-CSF + IL-4 + TNF-alpha. Both CD34(+) cell-derived and monocyte-derived DCs were able to process and to present tetanus toroid and keyhole limper hemocyanin to autologous T cells and to present major histocompatibility class I-binding peptides to CD8(+) cytotoxic T lymphocytes inducing interferon-gamma production. Altogether, these results suggest that DCs generated from CD34(+) cells of patients with breast cancer with flt3 ligand, c-kit ligand, GM-CSF, IL-4, and TNF-alpha are competent antigen-presenting cells, particularly for CD8(+) cytotoxic T lymphocytes, and resemble mature monocyte-derived DCs in the assays described here.
引用
收藏
页码:48 / 58
页数:11
相关论文
共 30 条
[1]  
BERNHARD H, 1995, CANCER RES, V55, P1099
[2]   Tumor antigens recognized by T cells [J].
Boon, T ;
Coulie, PG ;
VandenEynde, B .
IMMUNOLOGY TODAY, 1997, 18 (06) :267-268
[3]   CD34(+) hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to granulocyte-macrophage colony-stimulating factor plus tumor necrosis factor alpha .2. Functional analysis [J].
Caux, C ;
Massacrier, C ;
Vanbervliet, B ;
Dubois, B ;
Durand, I ;
Cella, M ;
Lanzavecchia, A ;
Banchereau, J .
BLOOD, 1997, 90 (04) :1458-1470
[4]   GM-CSF AND TNF-ALPHA COOPERATE IN THE GENERATION OF DENDRITIC LANGERHANS CELLS [J].
CAUX, C ;
DEZUTTERDAMBUYANT, C ;
SCHMITT, D ;
BANCHEREAU, J .
NATURE, 1992, 360 (6401) :258-261
[5]   The role of tumor necrosis factor α in modulating the quantity of peripheral blood-derived, cytokine-driven human dendritic cells and its role in enhancing the quality of dendritic cell function in presenting soluble antigens to CD4+ T cells in vitro [J].
Chen, BG ;
Shi, YJ ;
Smith, JD ;
Choi, D ;
Geiger, JD ;
Mulé, JJ .
BLOOD, 1998, 91 (12) :4652-4661
[6]   MURINE DENDRITIC CELLS PULSED IN-VITRO WITH TUMOR-ANTIGEN INDUCE TUMOR RESISTANCE IN-VIVO [J].
FLAMAND, V ;
SORNASSE, T ;
THIELEMANS, K ;
DEMANET, C ;
BAKKUS, H ;
BAZIN, H ;
TIELEMANS, F ;
LEO, O ;
URBAIN, J ;
MOSER, M .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (03) :605-610
[7]   Dendritic cells: Unique leukocyte populations which control the primary immune response [J].
Hart, DNJ .
BLOOD, 1997, 90 (09) :3245-3287
[8]   Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells [J].
Hsu, FJ ;
Benike, C ;
Fagnoni, F ;
Liles, TM ;
Czerwinski, D ;
Taidi, B ;
Engleman, EG ;
Levy, R .
NATURE MEDICINE, 1996, 2 (01) :52-58
[9]   GENERATION OF LARGE NUMBERS OF DENDRITIC CELLS FROM MOUSE BONE-MARROW CULTURES SUPPLEMENTED WITH GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR [J].
INABA, K ;
INABA, M ;
ROMANI, N ;
AYA, H ;
DEGUCHI, M ;
IKEHARA, S ;
MURAMATSU, S ;
STEINMAN, RM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (06) :1693-1702
[10]   The multi-epitope approach for immunotherapy for cancer: Identification of several CTL epitopes from various tumor-associated antigens expressed on solid epithelial tumors [J].
Kawashima, I ;
Hudson, SJ ;
Tsai, V ;
Southwood, S ;
Takesako, K ;
Appella, E ;
Sette, A ;
Celis, E .
HUMAN IMMUNOLOGY, 1998, 59 (01) :1-14